Bioengineering
Adnexus Therapeutics to Present Data on Adnectin Product Candidate, CT-322, at Gordon Research Conference
Published in Drug Law Weekly, September 4th, 2007
Adnexus Therapeutics, Inc. announced that the company will present data on CT-322, the company's first Adnectin product candidate, at The Gordon Research Conference on Angiogenesis and Microcirculation held in Newport, Rhode Island, August 19-24. The poster to be presented this afternoon by Irvith Carvajal, Senior Scientist, Ph.D. is titled "CT-322: A novel specific VEGFR-2-blocking protein therapeutic agent that inhibits tumor growth in preclinical studies."
CT-322 is an Adnectin that was designed to be both a potent and highly specific antagonist of the vascular endothelial growth factor receptor 2 (VEGFR-2). VEGFR-2 activation is believed to be the primary driver of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-09-04)
More Articles from Drug Law Weekly
- Allergies
Video: Food Allergies Mean Back-to-School Jitters for Millions of Students and Their Parents - Biopharmaceuticals
Expiry of Hart-Scott-Rodino waiting period for JUVISTA (human TGF3) - Biotech Business
Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel - Drug Abuse
Leading Panamanian Hospital Centro Medico Paitilla to Serve as Hythiam's Initial PROMETA Licensee for Central and South America - Drug Development
Abigail Alliance Will Appeal D.C. Circuit Court Decision - Drug Development
Research from Stanford University has provided new information about drug development - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
